GENE.V - Invictus MD Strategies Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.4850
-0.0150 (-3.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.5000
Open0.5200
Bid0.4800 x 0
Ask0.4900 x 0
Day's Range0.4700 - 0.5200
52 Week Range0.4700 - 2.3400
Volume456,446
Avg. Volume390,077
Market Cap59.817M
Beta (3Y Monthly)3.79
PE Ratio (TTM)N/A
EPS (TTM)-0.1880
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2016-11-17
1y Target Est2.25
  • GlobeNewswire12 days ago

    Invictus Withdraws Plans for NASDAQ Listing and Related Share Consolidation

    FRA: 8IS2) announced today that the Company is withdrawing plans to list the Company’s common shares (the “Shares”) on NASDAQ Stock Market LLC (“NASDAQ”), as well as plans for the share consolidation that would have been required to meet NASDAQ’s minimum share price listing threshold. Plans for the NASDAQ listing and a share consolidation were originally announced in press releases dated January 17, 2019 and January 21, 2019.

  • PR Newswire18 days ago

    Invictus Announces Appointment of Director and Chief Operating Officer

    FRA: 8IS2) the Company is pleased to announce the appointment of Trevor Dixon as a Director and Chief Operating Officer of the Company effective immediately.  Mr. Dixon is the founder, President and Chief Executive Officer of the Company's wholly owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms"). "Mr. Dixon brings 35 years of successful business experience to the leadership team of Invictus," said George E. Kveton, CEO of Invictus.

  • GlobeNewswirelast month

    INVICTUS GRANTS OPTIONS

    Vancouver, BC, April 26, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company has granted 200,000 incentive.

  • GlobeNewswirelast month

    Invictus To Develop CBD-Infused Sodas with Rock Icon Gene Simmons and Simmons’ Moneybag™ Sodas

    FRA: 8IS2) announced today that it has entered into a letter of intent (“LOI”) to form a Joint Venture (“JV”) with Gene Simmons (“Simmons”), Simmons’ MoneyBag Sodas (“MoneyBag™”) and  Rock Steady Sodas, Inc. (“Rock”) (each a “Party” and collectively the “Parties”) to develop a line of non-alcoholic, CBD-infused beverages for distribution in the United States and Canada. Rock will contribute expertise with existing premium soda recipes to be used with CBD and generations of bottling and distribution experience.

  • Did You Miss Invictus MD Strategies's (CVE:GENE) Impressive 116% Share Price Gain?
    Simply Wall St.last month

    Did You Miss Invictus MD Strategies's (CVE:GENE) Impressive 116% Share Price Gain?

    It hasn't been the best quarter for Invictus MD Strategies Corp. (CVE:GENE) shareholders, since the share price has fallen 25% in that time. But in three years the returns have been great. In fact, the share price is...

  • GlobeNewswire2 months ago

    INVICTUS MAKES FIRST SHIPMENT TO ONTARIO CANNABIS STORE

    Vancouver, BC, April 01, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment.

  • GlobeNewswire2 months ago

    GENE SIMMONS TAKES INVICTUS ON TOUR

    Vancouver, BC, March 25, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to report that the Company’s Chief.

  • GlobeNewswire2 months ago

    AB LABS AWARDED SALES LICENSE

    FRA: 8IS1) is pleased to announce that the Company’s licensed producer AB Labs Inc. (“AB Labs") has received a medical sales and processing license from Health Canada effective March 16, 2019, pursuant to the Cannabis Act and Cannabis Regulations (“CACR”). AB Labs, located in Hamilton, Ontario is at the heart of the Company’s presence in Eastern Canada, with its 16,000 square foot Phase 1 facility currently operating at full capacity, and its 40,000 square foot Phase 2 facility just weeks away from finalizing its Confirmation of Readiness submission to Health Canada.

  • GlobeNewswire2 months ago

    INVICTUS ANNOUNCES APPOINTMENT OF NEW CFO

    Vancouver, BC, March 15, 2019 -- INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce the appointment of.

  • GlobeNewswire3 months ago

    INVICTUS AND CANNAMERICA PROVIDE UPDATE ON HEMP AND CBD JOINT VENTURE

    FRA: 8IS1) is pleased to provide an update on its binding letter of intent to create a joint venture with Cannamerica Brands Corp. (CSE:CANA) (CNNXF) and CBDistribution Company Ltd. (collectively, the “Joint Venture”) that was previously announced on January 7, 2019, with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. The transaction is anticipated to close on or before March 31, 2019. Each of the parties involved have received approval from their respective Board of Directors to enter into the Joint Venture.

  • GlobeNewswire3 months ago

    INVICTUS PROVIDES PROGRESS UPDATE ON LICENSED PRODUCER EXPANSION

    FRA: 8IS1) is pleased to provide an update on production and expansion plans at its Licensed Producers: Acreage Pharms Ltd. (“Acreage Pharms”), AB Laboratories Inc. (“AB Labs”) and 0989561 B.C. Ltd. ("Canandia"). Invictus is proud to have fulfilled 100 per cent of provincial product orders to date and looks to further strengthen its sales and distribution relationships with both public and private enterprises as the Company’s facilities reach full operating capacity. A production footprint of 189,000 square feet is underway, with more capacity to come online commensurate with market needs and funding.

  • GlobeNewswire3 months ago

    INVICTUS PROVIDES UPDATE ON OIL EXTRACTION PROGRAM

    FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has successfully completed testing on two batches  of oil and is working to finalize its application to Health Canada to allow for the sale of bottled cannabis oil and cannabis resin. Acreage Pharms' closed-loop CO2 system performs Subcritical and Supercritical Fluid Extraction utilizing high-pressure carbon dioxide to extract essential oils from botanicals, using specific temperatures and pressures to withdraw different components from plants.

  • GlobeNewswire3 months ago

    INVICTUS SECURES SUPPLY AGREEMENT WITH THE ONTARIO CANNABIS RETAIL CORPORATION

    FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has signed an agreement to supply the Ontario Cannabis Retail Corporation (“OCRC”), through the Ontario Cannabis Store (“OCS”), with a selection of premium cannabis products for the adult recreational market. Acreage Pharms, located in Edson, Alberta, is Invictus’ largest purpose-built indoor facility fully licensed under the Cannabis Act and Cannabis Regulations.

  • GlobeNewswire3 months ago

    INVICTUS HIRES INTERIM CHIEF MARKETING OFFICER AND EXPANDS INVESTOR RELATIONS

    With over 35 years of branding experience in the healthcare sector, the Agency will leverage its expertise to help create, develop, and execute the go-to-market strategy for Invictus cannabis products. As interim CMO, the Agency will work with Authentic Brands Group (“ABG”) and Invictus’ senior leadership team to facilitate the anticipated launch of Invictus’ medical brand T2C, and adult recreational brands under Dukes and Sterling & Hunt.

  • ACCESSWIRE4 months ago

    LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index

    LOS ANGELES, CA / ACCESSWIRE / February 1, 2019 / LD Micro is pleased to announce that the LD Micro Index is being reconstituted as of February 1, 2019. Again. We have always held the belief that our industry ...

  • Market Exclusive4 months ago

    Cannabis Stock News Daily Roundup January 29

    Cannabis News Delta 9 Cannabis (OTCMKTS:VRNDF) inked a master license agreement with NanoSphere Health Sciences and its Canadian subsidiary NanoSphere Cannabis International. The agreement gives an exclusive license to Delta 9 in Canada to manufacture and sell products made with Nanosphere's patented technology for the delivery of cannabinoids via nanoparticle technology. Green Organic Dutchman Holdings […] The post Cannabis Stock News Daily Roundup January 29 appeared first on Market Exclusive.

  • GlobeNewswire4 months ago

    CBD Gummies In High Demand; International Spirits and Beverage Group (OTC: ISBG), Invictus MD Strategies, CV Sciences and Canopy Growth

    Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, releases a snapshot focused on the CBD edibles market and how, specifically, CBD gummies are in high demand. Building on that, Transparency Market Research expects the global market for gummy vitamins to rise at a steady CAGR of 5.2% during the period between 2017 and 2025. Last November, Canopy Growth Corporation (NYSE:CGC) (TSX:WEED.TO) started selling CBD-dominant softgels through its Tweed brand, containing 20 milligrams of CBD, and between 2.5 or 10 milligrams of THC.

  • PR Newswire4 months ago

    CannAmerica and Invictus Provide Update on Hemp and CBD Joint Venture

    FRA: 8IS1) is pleased to provide an update on its binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE:CANA) (CNNXF) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was previously announced on January 7, 2019 with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. Invictus is pleased to announce that it has received approval from its Board of Directors to enter into the Joint Venture with CannAmerica and CBDC.

  • CNW Group4 months ago

    Update: Invictus Nasdaq application and share consolidation

    FRA: 8IS1) announced today an update to its intention to proceed with a consolidation of its issued and outstanding shares with a newly proposed reduced share consolidation ratio of one new share for every five old shares (1:5) in connection with its proposed listing on Nasdaq Stock Market LLC ("Nasdaq"). The purpose of the consolidation is to increase the Company's common share price to be in compliance with Nasdaq's minimum share price listing requirement of USD $3.00 (CAD $3.98 ).

  • PR Newswire4 months ago

    Invictus' Canandia Awarded Sales License

    VANCOUVER , Jan. 21, 2019 /PRNewswire/ -  INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)  is pleased to announce that the Company's ...

  • PR Newswire4 months ago

    Invictus Executives to Represent Cannabis at World Economic Forum in Davos, Switzerland January 23 at 4pm GMT

    VANCOUVER , Jan. 17, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)  is pleased to announce that George E. Kveton, ...